Latest: The 2022 SelectScience Scientific Resource Bundles
Latest: The impact of COVID-19 on diabetic patients – watch on demand
Latest: Is there a link between SARS-CoV-2 infection and diabetes?
Latest: Top-rated lab products awarded new Seals of Quality
Latest: Utilizing new and unique GC column selectivities for optimal separation of dioxins,...
Latest: High-temperature ATR measurements of soaps and foodstuffs
Latest: World-class speaker lineup announced for Virtual Analytical Summit 2022
Is there a link between SARS-CoV-2 infection and diabetes?
Correlating breast cancer subtypes to clinical outcomes and targeted therapeutics in an era of...
New Cole-Parmer Overhead Mixers blend accuracy with durability for reliable stirring and mixing
Stevens AI expert to lead major project for NIH-funded Precision Nutrition and Health Hub
The 2022 SelectScience Scientific Resource Bundles
6 upcoming webinars to accelerate your research
A guide to efficient and greener cannabinoid purification
Increasing LC-MS accessibility for streamlined biotherapeutic analysis
Evaluation of high intensity lamps for AAS
Increase sensitivity with UltrAA lamps
Simplify your ICP-MS workflow
Interface cone comparison study
Cell Analysis Microscopy Equipment
Biophysical Characterization Technology
Virtual Clinical Science Summit
Virtual Cancer & Immunology Research Summit
05 Feb 22 - 09 Feb 22
Analytical Science Summit...
15 Feb 22 - 15 Feb 22
NEW: Infectious Disease &...
01 Mar 22 - 07 Mar 22
PITTCON Conference and Expo...
05 Mar 22 - 09 Mar 22
04 Apr 22 - 08 Apr 22
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have provided an update on the MOVe-OUT study of molnupiravir (MK-4482, EIDD-2801), an investi...Read Full ArticleDiane Li